IL4 and inflammatory bowel disease: In the context of IBD, which is closely linked to immune disorders and excessive M1 macrophage activation, the M2-polarizing effect of interleukin-4 (IL-4) plays a crucial therapeutic role (Egawa et al., 2013; Risser et al., 2023).